Načítá se...
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease
We evaluated the safety and effectiveness of adjunctive tacrolimus therapy with conventional immunosuppression in patients with severe connective tissue disease-related interstitial lung disease (CTD-ILD). We included patients from our interstitial lung disease (ILD) registry with CTD-ILD, in whom t...
Uloženo v:
| Vydáno v: | Pulm Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4760686/ https://ncbi.nlm.nih.gov/pubmed/26762710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pupt.2015.12.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|